发明名称 SUSTAINED RELEASE FORMULATION OF NALTREXONE
摘要 A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
申请公布号 US2016158225(A1) 申请公布日期 2016.06.09
申请号 US201615046373 申请日期 2016.02.17
申请人 Orexigen Therapeutics, Inc. 发明人 McKinney Anthony A.;Tollefson Gary D.;Soltero Richard;Dunzo Thea Elise
分类号 A61K31/485;A61K9/00;A61K31/137 主分类号 A61K31/485
代理机构 代理人
主权项
地址 La Jolla CA US